---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-111145"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:21:14.466263+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cyclacel gets Nasdaq extension to Dec 24, 2024 to meet equity minimum

## Summary
- Nasdaq Hearing Panel granted until Dec 24, 2024 to regain compliance with Rule 5550(b)(1).
- Company had stockholders' equity below $2.5 million as of June 30, 2024.
- No assurance compliance will be met; delisting risk remains if not regained by deadline.
- Listing Council may review panel decision within 45 days of Oct 22, 2024.

## SEC filing metadata
- accession: 0001104659-24-111145
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000110465924111145/0001104659-24-111145-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000110465924111145/tm2426738d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-111145
- JSON: https://secwatch.observer/filing/0001104659-24-111145.json
- Plain text: https://secwatch.observer/filing/0001104659-24-111145.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.